Research and development for clinical studies in the blueprint medtech. Clinical study protocol development. Task order 02. 06/17/2024 - 06/16/2029. Base and exercise 2 units of option quantity 1.
Active Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
PPD Development LP UEI ZANENSW6C665
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $324,420
Award facts
- Opportunity
-
- 75N95024F00001 Solicitation number
- Contract value 100% obligated
- $324,420.00 Current and potential, with all options
- Completion date 47% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Cape Fear, NC 28401, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $302,460 | |
| Exercise an Option | $14,640 | |
| Original award | $7,320 |
About this award
The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at $324,420 to PPD Development LP on June 17, 2024, for research and development supporting clinical studies under the Blueprint MedTech program. This task order, designated as Task Order 02, runs through June 16, 2029, and focuses specifically on clinical study protocol development. The contract carries a firm fixed price structure with no set-aside designation and will be performed at PPD Development LP's facility in Cape Fear, North Carolina. PPD Development LP, a subsidiary of Thermo Fisher Scientific and registered contract research organization, brings extensive experience in clinical trial management and regulatory support to the federal government.
As a child contract under a larger vehicle, this delivery order leverages PPD Development LP's established capacity to support NIDA's research initiatives. The contractor's qualifications are well-established through prior work with multiple federal agencies including the National Institutes of Health, Department of Defense, and other components of the Department of Health and Human Services. PPD Development LP's expertise in clinical protocol development, trial management, and specialized research services positions it to deliver comprehensive support for the Blueprint MedTech clinical studies that NIDA is advancing through this five-year engagement.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to PPD Development LP by National Institute on Drug Abuse (National Institutes of Health) on June 17, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $324,420 on 75N95024F00001.
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95023D00011, an indefinite delivery contract.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award